| 000 | 01867 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515031959.0 | ||
| 264 | 0 | _c20070109 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/j.lungcan.2006.05.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSovak, Mika A | |
| 245 | 0 | 0 |
_aRational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cAug 2006 |
||
| 300 |
_a177-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPleural Effusion _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aLutzker, Stuart | |
| 700 | 1 | _aZheng, Ling | |
| 700 | 1 | _aGuensch, Lisa | |
| 700 | 1 | _aJoyce, Margaret | |
| 700 | 1 | _aSchwartz, Susan | |
| 700 | 1 | _aWu, Yujun | |
| 700 | 1 | _aAisner, Joseph | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 53 _gno. 2 _gp. 177-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lungcan.2006.05.014 _zAvailable from publisher's website |
| 999 |
_c16384060 _d16384060 |
||